Federal-Mogul Goetze reported a consolidated net profit of ₹453.3 million for the first quarter of FY27 (ended June 30, 2026), a slight increase from ₹451.5 million in the corresponding period last year. The company’s consolidated revenue rose to ₹5,262.7 million, up from ₹4,836.7 million year-on-year, reflecting top-line growth despite persistent pressure on operating margins.

While the bottom line saw a marginal uptick, operational profitability faced headwinds. Consolidated EBITDA declined to ₹612.4 million from an estimated ₹706 million in the prior year period context, resulting in an EBITDA margin contraction to approximately 11.6%, down from 14.59% year-on-year. Standalone net profit was reported at ₹413.6 million, nearly flat at ₹414.3 million in the prior year quarter.

Financial Performance

The key financial metrics for the quarter are outlined below:

What the Numbers Show

The divergence between revenue growth and EBITDA performance indicates a squeeze on operating efficiency. While Federal-Mogul Goetze managed to grow its top line by nearly 9%, it failed to convert this volume or price growth into proportional operating profits. The decline in absolute EBITDA alongside rising revenue suggests that input costs or other operating expenses may have risen faster than sales, eroding the margin by nearly 300 basis points compared to the prior year.

Despite the margin contraction, the company maintained its net profit levels, indicating that non-operating items or tax efficiencies may have offset some of the operational pressure. The stability in net profit, despite weaker operating metrics, warrants monitoring in subsequent quarters to determine if this is a temporary fluctuation or a structural shift in profitability.

Federal-Mogul Goetze (India) Limited announced on July 31, 2026, that Dr. Khalid Iqbal Khan ceased to serve as its Whole-time Director-Legal & Company Secretary effective from the close of business hours on that date. The change in leadership occurs due to the completion of his tenure, marking a planned transition rather than an abrupt resignation or removal. This development affects the company’s legal and compliance oversight structure, requiring internal realignment of responsibilities within the Board of Directors.

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, the filing references the circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, as amended from time to time, ensuring full regulatory compliance. The intimation was submitted to both the Bombay Stock Exchange Limited and the National Stock Exchange of India Ltd.

Key Details of Cessation

Dr. Khalid Iqbal Khan (DIN: 05253556) tendered his resignation formally, expressing gratitude to the Board members and colleagues for their support during his tenure. His exit was accepted by Jyoti Mittal, confirming the procedural closure of his role. The announcement was signed by Amit Mittal (DIN: 02292626), Managing Director & Chief Financial Officer, underscoring the senior management’s acknowledgment of the transition.

What This Means for Governance

The departure of a Whole-time Director-Legal & Company Secretary represents a significant shift in the company’s corporate governance framework. As the primary officer responsible for legal compliance and company secretarial functions, Dr. Khan’s role was critical in ensuring adherence to statutory requirements and board protocols. His cessation necessitates immediate internal adjustments to maintain continuity in these vital areas.

While the source document does not specify a successor, the structured nature of the transition—driven by tenure completion rather than conflict—suggests a smooth handover process. Investors and stakeholders should monitor subsequent filings for any appointment of a new director or redistribution of duties among existing Board members. The company’s Corporate Identification Number remains L74899DL1954PLC002452, and its registered office is located at 803, Best Sky Tower, Netaji Subhash Place, New Delhi, 110034.